The immune response to stroke is comprised of inflammatory and regulatory processes. One cell type involved in both innate and adaptive immunity is the dendritic cell (DC). A DC population residing in the healthy brain (bDC) was identified using a transgenic mouse expressing enhanced yellow fluorescent protein (EYFP) under the promoter for the DC marker, CD11c (CD11c/EYFP Tg). To determine if bDC are involved in the immune response to cerebral ischemia, transient (40 min) middle cerebral artery occlusion (MCAO) followed by 6, 24, or 72 h reperfusion was conducted in CD11c/EYFP Tg mice. Our results demonstrated that DC accumulated in the ischemic hemisphere at 24 h post-MCAO-reperfusion, particularly in the border region of the infarct where T lymphocytes accrued. To distinguish resident bDC from the infiltrating peripheral DC, radiation chimeras [1. wild type (WT) hosts restored with CD11c/EYFP Tg bone marrow (BM) or 2. CD11c/EYFP Tg hosts restored with WT BM] were generated and examined by immunocytochemistry. These data confirmed that DC populating the core of the infarct at 72 h were of peripheral origin, whereas those in the border region were comprised primarily of resident bDC. The brain resident (CD45 intermediate) cells of CD11c/EYFP Tg mice were analyzed by flow cytometry. Compared to microglia, bDC displayed increased major histocompatibility class II (MHC II) and co-stimulatory molecules following MCAO-reperfusion. High levels of MHC II and the co-stimulatory molecule CD80 on bDC at 72 h corresponded to peak lymphocyte infiltration, and suggested a functional interaction between these two immune cell populations.
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Introduction
It was common conception that the central nervous system (CNS) was an immune-privileged site and did not contain a resident population of the professional antigen presenting cells (APC), dendritic cells (DC). However, brain origin cells that express mature DC markers in response to damage or disease have engendered speculation that a resident immune cell population may serve as a DC precursor (Butovsky et al., 2007 (Butovsky et al., , 2006 Fischer and Reichmann, 2001; Santambrogio et al., 2001) . Most mature DC subsets display the surface protein CD11c (Integrin alpha x, p150/90 chain) as a heterodimer with CD18, thus CD11c is considered a pan DC marker. A transgenic (Tg) mouse expressing enhanced yellow fluorescent protein (EYFP) under the promoter for CD11c (CD11c/EYFP Tg) was developed to track DC during the steady state. This mouse revealed a population of resident CD11c/EYFPexpressing DC in the healthy central nervous system (CNS), termed brain (b)DC, that were characterized by Bulloch and colleagues (2008) . The bDC were located in discrete neuroanatomic regions and were prominent in the fiber tracts, circumventricular organs, regions accessible to intranasal antigen exposure, and sites of postnatal neurogenesis. Furthermore, these cells accumulated in regions of damage following kainic acid-induced seizure and displayed morphologies distinct from that of brain resident microglia (MG). Recent studies from our laboratory have demonstrated that resident bDC can be further distinguished from MG by their potent APC capabilities and TH1 cytokine production (Gottfried-Blackmore et al., 2009), suggesting they may be involved in inflammatory processes in the CNS.
One model of brain damage that induces immune activation is cerebral ischemia. This immune response to ischemic stroke is characterized by early inflammatory and later regulatory components, the outcome of which contributes to the extent of damage and functional recovery (Doyle et al., 2008; McColl et al., 2009; Offner et al., 2009) . Given the role of DC in bridging innate and adaptive immunity in the periphery (Steinman and Banchereau, 2007) , the bDC may be involved in the balance between inflammation and protection
